Associated High Confidence AOPs |
---|
For more information or term definitions, please refer to
HELP page.
Associated AOPs with Level of Relevance 1
AOP Identifier |
AOP Title |
AO Classification |
OECD Status |
Coverage Score |
KE Identifier |
KE Name |
AOP:164 | Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse | Cancer; Reproductive System Disease | - | 0.17 | KE:1043 | Hypertrophy/hyperplasia, smooth muscle |
AOP:439 | Activation of the AhR leading to metastatic breast cancer | Thoracic Disease; Cancer | Under Development | 0.11 | KE:1241 | Increased, Motility |
AOP:493 | ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity | Acquired Metabolic Disease | - | 0.1 | KE:2119 | Insulin resistance, increased |
Associated AOPs with Level of Relevance 2
AOP Identifier |
AOP Title |
AO Classification |
OECD Status |
Coverage Score |
KE Identifier |
KE Name |
AOP:457 | Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine | Inherited Metabolic Disorder | - | 0.17 | KE:2119 | Insulin resistance, increased |
AOP:463 | The AOP framwork on silica nanopariticles induced hepatoxicity | Gastrointestinal System Disease | - | 0.09 | KE:2034 | liver dysfunction |
AOP:497 | ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome | Inherited Metabolic Disorder; Disease Of Metabolism | - | 0.12 | KE:2119 | Insulin resistance, increased |
No associated AOPs with Level of Relevance 3
No associated AOPs with Level of Relevance 5